Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
5 studies found for:    4938153 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
Condition: Glioblastoma Multiforme
Intervention:
2 Completed A Phase I Trial of SS1 (dsFv) PE38 With Paclitaxel, Carboplatin, and Bevacizumab in Subjects With Unresectable Non-Small Cell Lung Adenocarcinoma
Conditions: Non-Small Cell Lung Cancer;   Adenocarcinoma
Interventions: Drug: SS1 (dsFv) PE38;   Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Bevacizumab
3 Terminated A Prospective, Open, Non-randomized Phase I/II Study of Therapeutic Angiogenesis in Diabetic Patients With Critic Ischemia of Lower Limbs While Administering Positive CD133 Mobilized With G-CSF
Condition: Diabetic Patients With Critic Ischemia in Lower Limbs Who Are Administered With CD133+ Cells Mobilized by G-CSF
Intervention: Biological: CD133+ cells transplant
4 Terminated
Has Results
A Phase II Safety and Tolerability Study of Bevacizumab When Added to Single-agent Chemotherapy to Treat Patient With Breast Cancer Metastatic to Brain
Condition: Breast Cancer
Interventions: Drug: Bevacizumab;   Drug: Docetaxel;   Drug: CPT-11;   Drug: Paclitaxel;   Drug: Vinorelbine Tartrate;   Drug: Gemcitabine
5 Terminated
Has Results
Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction
Conditions: Esophageal Neoplasms;   Esophageal Diseases
Interventions: Drug: Erlotinib;   Drug: Avastin

Study has passed its completion date and status has not been verified in more than two years.